Clinicians are trained to practice evidence-based medicine, yet the realities of care often reveal its limits. In many situations, the literature does not offer clear guidance for the patient in front of us. A large share of clinical decisions are made without high-quality evidence. This is not a failure of clinical judgment. It reflects a
Read more…
Evidence-based medicine needs real-world data to evolve originally appeared in KevinMD.com.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
